• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Punctal occlusion often overlooked in management of dry eye disease


Punctal plugs play an important role in the management of dry eye disease, but punctal occlusion is a dramatically underused intervention.

"The treatment recommendations for [DED] issued in 2007 by members of the Management and Therapy Subcommittee of the International Dry Eye WorkShop list punctal plugs as an option for patients with Level 2, moderate-type disease. However, available statistics indicate that only about 12% to 15% of ophthalmologists and optometrists are using this modality," said Dr. Potaznick, associate professor of optometry, Northeastern College of Optometry, Boston.

Needs assessment

Qualifying candidates

Evaluation to identify appropriate candidates should include measurement of tear breakup time, tear meniscus, ocular surface staining with both fluorescein and lissamine green, Schirmer's test or phenol red thread test to assess tear production, and a symptom questionnaire. The latter is also particularly helpful for documenting patient response, Dr. Potaznick noted.

"Improvement in patients with [DED] is a slow and gradual process. It is useful to have some metric to prove to patients they are benefiting from intervention," he explained.

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.